Colgate-Palmolive (NYSE: CL) is one of 32 publicly-traded companies in the “Personal Products” industry, but how does it compare to its competitors? We will compare Colgate-Palmolive to related companies based off the strength of its analyst recommendations, profitability, risk, earnings, dividends, valuation and institutional ownership.

Volatility and Risk

Colgate-Palmolive has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Colgate-Palmolive’s competitors have a beta of 1.09, meaning that their average stock price is 9% more volatile than the S&P 500.


This table compares Colgate-Palmolive and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Colgate-Palmolive 15.83% 3,121.95% 20.57%
Colgate-Palmolive Competitors 5.72% 157.10% 7.36%

Earnings & Valuation

This table compares Colgate-Palmolive and its competitors revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Colgate-Palmolive $15.18 billion $4.42 billion 26.70
Colgate-Palmolive Competitors $14.46 billion $2.91 billion 13.98

Colgate-Palmolive has higher revenue and earnings than its competitors. Colgate-Palmolive is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently the more expensive than other companies in its industry.


Colgate-Palmolive pays an annual dividend of $1.60 per share and has a dividend yield of 2.2%. Colgate-Palmolive pays out 59.5% of its earnings in the form of a dividend. As a group, “Personal Products” companies pay a dividend yield of 2.0% and pay out 46.2% of their earnings in the form of a dividend. Colgate-Palmolive has raised its dividend for 53 consecutive years.

Analyst Recommendations

This is a breakdown of recent ratings for Colgate-Palmolive and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Colgate-Palmolive 0 10 2 0 2.17
Colgate-Palmolive Competitors 363 1092 1238 28 2.34

Colgate-Palmolive presently has a consensus target price of $74.80, suggesting a potential upside of 4.15%. All “Personal Products” companies have a potential downside of 1.73%. Given Colgate-Palmolive’s higher possible upside, equities research analysts clearly believe Colgate-Palmolive is more favorable than its competitors.

Insider & Institutional Ownership

73.2% of Colgate-Palmolive shares are owned by institutional investors. Comparatively, 57.6% of shares of all “Personal Products” companies are owned by institutional investors. 1.0% of Colgate-Palmolive shares are owned by insiders. Comparatively, 15.4% of shares of all “Personal Products” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.


Colgate-Palmolive beats its competitors on 9 of the 15 factors compared.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company’s oral care products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh and Colgate Optic White. The Company is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. The Company manufactures and markets a range of products for the home care market, including Palmolive and Ajax dishwashing liquids, Fabuloso and Ajax household cleaners and Murphy’s Oil Soap. The Company, through its Hill’s Pet Nutrition segment (Hill’s), manufactures pet nutrition products for dogs and cats.

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with's FREE daily email newsletter.